SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Guilford (GLFD) - Steadily Rising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Dwyer who wrote (67)8/24/1997 1:40:00 AM
From: James Silverman   of 496
 
A couple more points.
First, its $35M upfront which as you note consists of $15M cash, $15M equity investment and $5M for warrants. This is all in the coffers immediately. Should the warrants be exercised GLFD would be looking at an additional $20M or so.
Second, should these drugs be successfully developed it will be a bargain for AMGN, but GLFD would still have much more upside leverage given its far lower valuation.
Thats about all. Hope you had a nice vacation.

Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext